Strategic Partnerships Inpeco has active collaboration with Qiagen and Diasorin to develop track-based automation for QuantiFERON IGRA workflows, presenting a compelling cross-sell opportunity to expand into infectious disease testing automation and end-to-end sample processing solutions.

Expansion Momentum Recent announcements emphasize fully automated QuantiFERON workflows and incubation/aliquoting innovations, indicating a growth trajectory in advanced automation for specialized immunodiagnostics, which can drive upsell of FlexLab track systems and related software.

Global Footprint With shipments to 78 countries and a global leadership position in Total Laboratory Automation, there are opportunities to tailor regional deployments, service contracts, and local validation packages to win multi-site laboratory wins and maintain recurring revenue.

Product Leadership Awards and market premieres of next-generation automation at major industry events signal a technology-led value proposition; sales teams can leverage this to position upgrades, modular expansions, and cross-vertical applications such as pathology, blood banks, and life sciences.

Integrated Ecosystem The tech stack and existing partnerships suggest a capability to offer integrated data connectivity, traceability, and analytics across laboratories, enabling upsell of data integration, middleware, and analytics modules to improve test security and productivity.